NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)

Clinical trial NCT03968354 · UNKNOWN

Trial details

NCT number: NCT03968354
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Study type: OBSERVATIONAL

Diabetes type2 NASH - Nonalcoholic Steatohepatitis NAFLD

Start date: 2020-02-01
Primary completion: 2021-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.